Evidence map›Paper›PMID 23592263›Full record

ArticlemBio2013

In-depth analysis of the interaction of HIV-1 with cellular microRNA biogenesis and effector mechanisms.

Adam W Whisnant, Hal P Bogerd, Omar Flores, Phong Ho, Jason G Powers, Natalia Sharova, Mario Stevenson, Chin-Ho Chen, Bryan R Cullen

Open access · goldAbstract read
In one paragraph

Article in mBio, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 96 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
96citing papers in PubMed, 2 pooled it
6.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

96 citing papers in PubMed, 2 syntheses or guidelines pooled it, 149 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review

36 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Adam W WhisnantDepartment of Molecular Genetics & Microbiology and the Center for Virology, Duke University Medical Center, Durham, North Carolina, USA.
Hal P Bogerd
Omar Flores
Phong Ho
Jason G Powers
Natalia Sharova
Mario Stevenson
Chin-Ho Chen
Bryan R Cullen
Duke Medical Center · USDuke University Hospital · USUniversity of Miami · USDuke University · US

Funding

Social and Behavioral Sciences CoreP30AI064518 · NIAID · DUKE UNIVERSITY · PI Nwora Lance Okeke · 2005 to 2026
$50.5M
University of Miami Developmental Center for AIDS Research (D-CFAR)P30AI073961 · NIAID · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI ALLAN E RODRIGUEZ · 2007 to 2026
$33.8M
Viral reservoirs and sanctuaries in HAART - treated patients: role and mechanismsU19AI096109 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI SCHACKER, TIMOTHY W · 2011 to 2015
$29.5M
Viral Oncology Training GrantT32CA009111 · NCI · DUKE UNIVERSITY · PI LUFTIG, MICAH A. · 1985 to 2023
$8.9M
VIF Anatagonists: Antiviral Evaluation in Vitro, Inhibitor resistance and MoleU19MH081836 · NIMH · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI RANA, TARIQ M · 2007 to 2012
$6.3M
Betulinic acid derivatives as anti-HIV agents.R01AI065310 · NIAID · DUKE UNIVERSITY · PI CHEN, CHIN-HO · 2006 to 2014
$3.1M
HIV-1: microRNA interactionsR01DA030086 · NIDA · DUKE UNIVERSITY · PI CULLEN, BRYAN R. · 2010 to 2014
$1.9M
NCI NIH HHS T32 CA009111NCI NIH HHS T32-CA009111NIAID NIH HHS 5P30-AI064518NIAID NIH HHS P30 AI064518NIAID NIH HHS P30 AI073961NIAID NIH HHS P30-AI073961NIAID NIH HHS R01 AI065310NIAID NIH HHS R01-AI065310NIAID NIH HHS U19 AI096109NIAID NIH HHS U19-AI096109NIDA NIH HHS R01 DA030086NIMH NIH HHS U19 MH081836NIMH NIH HHS U19-MH081836
6 · The paper itself

Abstract

unlabelledThe question of how HIV-1 interfaces with cellular microRNA (miRNA) biogenesis and effector mechanisms has been highly controversial. Here, we first used deep sequencing of small RNAs present in two different infected cell lines (TZM-bl and C8166) and two types of primary human cells (CD4(+) peripheral blood mononuclear cells [PBMCs] and macrophages) to unequivocally demonstrate that HIV-1 does not encode any viral miRNAs. Perhaps surprisingly, we also observed that infection of T cells by HIV-1 has only a modest effect on the expression of cellular miRNAs at early times after infection. Comprehensive analysis of miRNA binding to the HIV-1 genome using the photoactivatable ribonucleoside-induced cross-linking and immunoprecipitation (PAR-CLIP) technique revealed several binding sites for cellular miRNAs, a subset of which were shown to be capable of mediating miRNA-mediated repression of gene expression. However, the main finding from this analysis is that HIV-1 transcripts are largely refractory to miRNA binding, most probably due to extensive viral RNA secondary structure. Together, these data demonstrate that HIV-1 neither encodes viral miRNAs nor strongly influences cellular miRNA expression, at least early after infection, and imply that HIV-1 transcripts have evolved to avoid inhibition by preexisting cellular miRNAs by adopting extensive RNA secondary structures that occlude most potential miRNA binding sites. IMPORTANCE: MicroRNAs (miRNAs) are a ubiquitous class of small regulatory RNAs that serve as posttranscriptional regulators of gene expression. Previous work has suggested that HIV-1 might subvert the function of the cellular miRNA machinery by expressing viral miRNAs or by dramatically altering the level of cellular miRNA expression. Using very sensitive approaches, we now demonstrate that neither of these ideas is in fact correct. Moreover, HIV-1 transcripts appear to largely avoid regulation by cellular miRNAs by adopting an extensive RNA secondary structure that occludes the ability of cellular miRNAs to interact with viral mRNAs. Together, these data suggest that HIV-1, rather than seeking to control miRNA function in infected cells, has instead evolved a mechanism to become largely invisible to cellular miRNA effector mechanisms.

Indexed as

Host-Pathogen InteractionsCD4-Positive T-LymphocytesCells, CulturedGene Expression Regulation, ViralHigh-Throughput Nucleotide SequencingHIV-1HumansMacrophagesMicroRNAsRNA, MessengerRNA, ViralMicroRNAsRNA, MessengerRNA, Viral

Identifiers

PMID23592263
PMCPMC3634607
OpenAlexW2158989286

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.